Endotoxin Activity Test Manufacturer Claims Superiority Over Cultures Alone
This article was originally published in The Gray Sheet
Executive Summary
Spectral Diagnostics' assay for ruling out gram-negative infection to aid antibiotic prescribing practices will go before CDRH's Microbiology Devices Panel in Gaithersburg, Maryland Oct. 11.